BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8349789)

  • 1. Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition.
    Hutchison FN; Webster SK; Jaffa AA
    J Clin Invest; 1993 Aug; 92(2):1073-9. PubMed ID: 8349789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome.
    Hutchison FN; Martin VI
    Am J Physiol; 1990 May; 258(5 Pt 2):F1237-44. PubMed ID: 1692447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat.
    Jaffa AA; Vio C; Velarde V; LeRoith D; Mayfield RK
    Diabetes; 1997 Dec; 46(12):2049-56. PubMed ID: 9392495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension.
    Von Thun AM; el-Dahr SS; Vari RC; Navar LG
    Hypertension; 1994 Jan; 23(1 Suppl):I131-6. PubMed ID: 7506697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition.
    Gomez RA; Lynch KR; Chevalier RL; Everett AD; Johns DW; Wilfong N; Peach MJ; Carey RM
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F900-6. PubMed ID: 2837909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of converting enzyme inhibition on renin synthesis and secretion in mice.
    Barrett GL; Morgan TO; Smith M; Alcorn D; Aldred P
    Hypertension; 1989 Oct; 14(4):385-95. PubMed ID: 2551820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly increased urinary preprohaptoglobin and haptoglobin in passive Heymann nephritis: a differential proteomics approach.
    Ngai HH; Sit WH; Jiang PP; Thongboonkerd V; Wan JM
    J Proteome Res; 2007 Aug; 6(8):3313-20. PubMed ID: 17616219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephritis blunts urinary kallikrein excretion and aggravates DOCA/NaCl hypertension in rats.
    Prado EB; Prado MJ; Marcondes M
    Braz J Med Biol Res; 1988; 21(5):919-25. PubMed ID: 3248240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: urinary kallikrein excretion as a possible recovery index.
    Girolami JP; Orfila C; Pecher C; Cabos-Boutot G; Bascands JL; Moatti JP; Adam A; Colle A
    Biol Chem Hoppe Seyler; 1989 Dec; 370(12):1305-13. PubMed ID: 2619924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
    Thaiss F; Haas C; Helmchen U; Wenzel U; Stahl RA
    Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal kallikrein excretion as a distal nephrotoxicity marker during cadmium exposure in rats.
    Girolami JP; Bascands JL; Pécher C; Cabos G; Moatti JP; Mercier JF; Haguenoer JM; Manuel Y
    Toxicology; 1989 Apr; 55(1-2):117-29. PubMed ID: 2652377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin expression in renal proximal tubule.
    Moe OW; Ujiie K; Star RA; Miller RT; Widell J; Alpern RJ; Henrich WL
    J Clin Invest; 1993 Mar; 91(3):774-9. PubMed ID: 7680667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin and renin mRNA in proximal tubules of the rat kidney.
    Chen M; Harris MP; Rose D; Smart A; He XR; Kretzler M; Briggs JP; Schnermann J
    J Clin Invest; 1994 Jul; 94(1):237-43. PubMed ID: 8040265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin and renin-angiotensin systems in nephrotic syndrome.
    Cumming AD; Jeffrey S; Lambie AT; Robson JS
    Nephron; 1989; 51(2):185-91. PubMed ID: 2644571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.